Completion rates of intraperitoneal chemotherapy for stage III epithelial ovarian cancer in a community integrated health care system

被引：0
|
作者：
Lazo, I. [1 ]
White, K. [1 ]
Tucker, L. [2 ]
Zaritsky, E. [1 ]
Han, L. [1 ]
Ciaravino, G. [1 ]
机构：
[1] Kaiser Permanente, Oakland Med Ctr, Dept Obstet & Gynecol, Oakland, CA USA
[2] Kaiser Permanente, Div Res, Oakland, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 139卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2015.07.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [41] Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
    Jaaback, Kenneth
    Johnson, Nick
    Lawrie, Theresa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [42] Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer
    Kurt Van der Speeten
    Anthony O Stuart
    Paul H Sugarbaker
    World Journal of Obstetrics and Gynecology, 2013, (04) : 143 - 152
  • [43] Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer - Single Center Experience
    Jaka, Rajshekhar C.
    Somashekhar, S. P.
    Zaveri, Shabber S.
    Ahmed, Zahoor
    Ashwin, K. R.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2012, 3 (03) : 262 - 266
  • [44] Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
    Jaaback, Kenneth
    Johnson, Nick
    Lawrie, Theresa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [45] Intraperitoneal chemotherapy in patients with stage III ovarian cancer: Differences in outcome based on lymph node and intraperitoneal disease status
    Dholakiya, P.
    Krohn, M.
    Button, A.
    Racek, A.
    McDonald, M. E.
    Goodheart, M. J.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 405 - 405
  • [46] RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer
    Cascales Campos Pedro Antonio
    Muñoz-Casares Francisco-Cristobal
    Gonzalez-Gil Alida
    Sánchez-García Susana
    Manzanedo Israel
    Morales Rafael
    Padilla-Valverde David
    Villarejo Pedro
    Pereira Fernando
    Gil Elena
    Gil José
    Clinical & Experimental Metastasis, 2021, 38 : 255 - 255
  • [47] Intraperitoneal chemotherapy improves oncologic outcome in stage IIIC epithelial ovarian cancer patients with miliary subtype
    Manning-Geist, B. L.
    Schorge, J. O.
    Growdon, W. B.
    del Carmen, M. G.
    Clark, R. M.
    Muto, M. G.
    Matulonis, U. A.
    Horowitz, N. S.
    Berkowitz, R. S.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 135 - 135
  • [48] Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.
    Loizzi, V
    Cormio, G
    Di Vagno, G
    Resta, L
    Cazzolla, A
    Di Gilio, A
    Cuccovillo, A
    Selvaggi, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 478S - 478S
  • [49] A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer
    Bouchard-Fortier, Genevieve
    Rosen, Bany
    Vyarvelska, Tryna
    Pasetka, Mark
    Covens, Allan
    Gien, Lilian T.
    Kupets, Rachel
    Pulman, Katherine
    Ferguson, Sarah E.
    Vicus, Danielle
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 36 - 41
  • [50] Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy
    Strathdee, G
    Vass, JK
    Oien, KA
    Siddiqui, N
    Curto-Garcia, J
    Brown, R
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 898 - 903
12345